<DOC>
	<DOCNO>NCT02812979</DOCNO>
	<brief_summary>The principal objective show noninferiority nebulized salbutamol high flow nasal system moisten AIRVO â„¢ 2 term reversibility airflow obstruction compare nebulization usual method ( spray mask ) .</brief_summary>
	<brief_title>Evaluation Effectiveness Nebulization Bronchodilators Under High Nasal Flow Humidified</brief_title>
	<detailed_description>Randomized , comparative , non inferiority study two nebulization strategy bronchodilator , one accord method test namely spray - across top humidify nasal flow system accord customary procedure , mask . A third arm evaluate ( control arm ) overcome possible bronchodilator effect high flow nasal humidify .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>adult Patient chronic obstructive pulmonary disease Patients , perform lung function test perform outside study : 1 . A report FEV / FVC le 60 % prior bronchodilator treatment AND 2 . A positive reversal test define FEV variation 12 % 200 mL administration inhale salbutamol Patients affiliate social security scheme Informed consent sign patient Exacerbation chronic obstructive pulmonary disease Uncontrolled asthma Pneumothorax current recent ( &lt; 2 month ) Pleural aspiration biopsy , trans bronchial biopsy / bronchoalveolar lavage precede 48h hemoptysis progress Patient guardianship trusteeship safeguard justice Pregnant breastfeed woman parturient woman Known allergy intolerance salbutamol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>